EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer

Andrea Lancia iD, Marco Oderda iD, Federico Camilli, Eleonora Festa, Marta Bottero iD, Emanuele Alì iD, Salvatore La Mattina iD, Elisabetta Bonzano iD, Jessica Saddi, Beatrice Detti, David Alberto Santos Hernandez iD, Gianluca Ingrosso

Pharmaceuticals · 08.11.2025 · 18 (11) · 1697

DOI: 10.3390/ph18111697 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 08.11.2025. Verfasst von Andrea Lancia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the second most common cancer in men, and it is frequently diagnosed at an advanced stage of the disease. Androgen Deprivation Therapy (ADT) has traditionally represented the backbone of therapy for high-risk, recurrent, and metastatic disease; however, in the last ten years a new group of molecules known as androgen receptor pathway inhibitors (ARPIs) have been demonstrated to improve outcomes in metastatic patients when added to ADT. Developed and validated originally in the setting of castration-resistant disease, ARPIs have been implemented progressively earlier in the natural history of PCa, involving patients who have never received ADT before or that are still responsive to this treatment. Considering the strong evidence for treatment intensification in patients with high-risk features, with this review we aim to provide a complete overview of the current indications for the use of ARPIs through all the stages of castration-sensitive prostate cancer (CSPC).

Schlagwörter

Stichwörter der Autor:innen

androgen receptor pathway inhibitormetastasesprostate cancerradiotherapysurgery

Autor:innen und Institutionen

  • Radiation Oncology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, 10124 Turin, Italy.
  • Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia and Perugia General Hospital, 06156 Perugia, Italy.
  • Radiotherapy Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
  • Radiation Oncology Unit, Azienda Unitaria Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico, 42123 Reggio Emilia, Italy.
  • Radiotherapy Unit Prato, Usl Centro Toscana, Presidio Villa Fiorita, 59100 Prato, Italy.

ORCID-Profile: Andrea Lancia, Marco Oderda, Marta Bottero, Emanuele Alì, Salvatore La Mattina, Elisabetta Bonzano, David Alberto Santos Hernandez

Zitieren

APA

Lancia, A., Oderda, M., Camilli, F., Festa, E., Bottero, M., Alì, E., La Mattina, S., Bonzano, E., Saddi, J., Detti, B., Santos Hernandez, D. A., & Ingrosso, G. (2025). Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer. Pharmaceuticals, 18(11), 1697. https://doi.org/10.3390/ph18111697

Vancouver

Lancia A, Oderda M, Camilli F, Festa E, Bottero M, Alì E, et al. Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer. Pharmaceuticals. 2025;18(11):1697. doi:10.3390/ph18111697

BibTeX
@article{Lancia2025,
  author = {Lancia, Andrea and Oderda, Marco and Camilli, Federico and Festa, Eleonora and Bottero, Marta and Alì, Emanuele and La Mattina, Salvatore and Bonzano, Elisabetta and Saddi, Jessica and Detti, Beatrice and Santos Hernandez, David Alberto and Ingrosso, Gianluca},
  title = {Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {11},
  pages = {1697},
  doi = {10.3390/ph18111697}
}
Kostenlos starten →